Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Oncolytics Biotech Inc T.ONC

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ONCY

Oncolytics Biotech, Inc., is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers.
Price: $0.85 | Change: $-0.05 | %Change: -5.56%
Volume: 446,747 | Day High/Low: 0.92/0.80 | 52 Week High/Low: 3.49/0.77
View modes: 
0 stars

ONC - 4.00 PT with a "BUY" rating!!!!!!!!!!!!  rate and reply
0 stars

The sky is not falling chicken little

Oncolytics did present additional data for a subgroup of patients with a certain gene mutation known as KRAS. In this patient population, the REOLYSIN arm showed a small benefit in progression more
0 stars

RE:This is why I'm in - NEW ARTICLE!!!!

BaystreetBrian wrote: I saw that more
5 stars

This is why I'm in - NEW ARTICLE!!!!  rate and reply
0 stars


Birch....we must share a mind, cuz you took my thoughts and typed them you, I'm in!  rate and reply
0 stars


LOL, they just started the next testing for Ovarian Cancer.  Some promise for sure on the last one, so, I took some today and will stick around.  Especially, because, if the news was that bad, I more
0 stars


ONC is all but finished. Get what is left of your investment now....on its way to pennies. SELL!  rate and reply
0 stars


Someone pointed me here this morning.  Not sure why the panic with only 1% of the float dumped.  Seems like it is the end of the world or something, but not when you look at volume. GL  rate and reply
0 stars


This was put out yesterday and released this morning. Paradigm Capital Reaffirms Buy Rating for Oncolytics Biotech (ONC) Posted by Logan Wallace on Sep 17th, 2014 // No Comments more
0 stars


Drop it like its hot.    It`s been downgraded by some analysts and the results from it`s latest clinical trials were underwhelming.  rate and reply
4 stars


Time ET Ex Price Change Volume Buyer Seller Markers 09:35:09 T 0.94 -0.46 50 2 RBC more
2 stars

RE:RE:Answers, Issues, Questions

Bunge, With 10K shares, you might get to $100G in six months! Lots of news coming up, including panc results in less than two weeks. Its getting the $1 mil that might take 2-3 years. WC  rate and reply
0 stars

RE:Fund Security

Oncy has cash on hand sufficient until October 2015. The float is relatively small and the company has always had the ability to raise cash when needed. After the end of September, the share price more
5 stars

Fund Security

Thinking about taking a small position, quick question to the board - how secure is ONCY's funding?  rate and reply
5 stars

RE:ESMO BT may end up with no money. GCS is using the common more
5 stars


On September 28,2014 at 12:45 Dr Saab will present the results of the Phase 2 First Line treatment for Pancreatic Cancer. If his previous positive comments are bourne out by the results, this more
0 stars

RE:Answers, Issues, Questions

Thanks for the post and kudos. Jumped in for a small position.  Only 10,000 shares. Puttin' them in my back pocket.  Hoping all goes well.  Make $100G in 2 - 3 years.  :P  rate and reply
3 stars

Answers, Issues, Questions

A big thank-you goes out for not ridiculing my last post and to Bunge for initiating a discussion. Bunge noted that Oncolytics is a good buy. The contrived trading price was confirmed and Bunge more
0 stars

Article on Seeking Alpha for ONC!!

Update: Oncolytics Biotech Earnings Aug. 15, 2014 8:53 AM ET  |  About: Oncolytics Biotech, Inc. (ONCY) Disclosure: The author has no positions in more
2 stars

RE:RE:RE:Missing something?

Yeah, this one requires lots of patience. I have been in for awhile now, bought in this range many years ago, watched it go up to 6 and back down to its present price. Lots of potential here but more